New company co-founded by Rice faculty member aims to move beyond symptom management in preeclampsia

The Quick Take
Emvena emerges from stealth with investment from the PxB Fund HOUSTON, Nov. 4, 2026 /PRNewswire/ -- Emvena Therapeutics, Inc., a biotechnology company co-founded by Rice University faculty member Kelsey Swingle announces its launch to develop a treatment for preeclampsia, a serious...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
Fleet Management Software Market worth $6.41 billion by 2033 - Exclusive Report by MarketsandMarkets™
DELRAY BEACH, Fla., Nov. 4, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the global fleet management software market is projected to grow from USD…
Business
Levi & Korsinsky Reminds Ryde Group Ltd Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 9, 2026 - RYDE
Forensic research publicly warned on September 9, 2024 that Ryde Group Ltd carried "all the hallmarks" of a pump-and-dump; two days later a securities class…
Business
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 28, 2026 in Tenax Therapeutics, Inc. Lawsuit - TENX
Key Dates and Disclosure Events: a 33-month Tenax timeline traces how the Company allegedly built confidence in TNX-103 across three financings before its…
Business
Levi & Korsinsky Reminds Millrose Properties Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 8, 2026 - MRP
Important Information Regarding Section 20(a) Individual Liability Claims: The lawsuit names Millrose's CEO and CFO, who allegedly signed SEC filings pledging…
